Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings
- PMID: 31128225
- DOI: 10.1016/j.mri.2019.05.032
Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings
Abstract
Purpose: Dynamic contrast enhanced MRI (DCEMRI), diffusion weighted imaging (DWI) and in vivo proton (1H) magnetic resonance spectroscopy (MRS) provides functional and molecular nature of breast cancer. This study evaluates the potential of the combination of three MR parameters [curve kinetics, apparent diffusion coefficient (ADC) and total choline (tCho) concentration] determined from these techniques in increasing the sensitivity of breast cancer detection.
Methods: MR investigations were carried out at 1.5 T on 56 patients with cytologically/histologically confirmed breast carcinoma. Single-voxel MRS was used to determine the tCho concentration. 3D FLASH was used for DCEMRI while single shot EPI based DWI was used for ADC determination.
Results: On DCEMRI, one patient showed type I curve, while 8 showed type II and 47 showed type III curve thus giving a sensitivity of 83.9% as detection rate of malignancy. tCho concentration was above cut-off value (2.54 mmol/kg) for 50/56 cases giving a sensitivity of 89.3%. Among 9 indeterminate DCEMRI cases, tCho showed malignancy in 6 cases with type II curve. DWI detected malignancy in 54/56 cases that included 9 cases that were false negative on DCEMRI, yielding a sensitivity of 96.4%. A total of 54 cases showed malignancy when any two of the three MR parameters was positive for malignancy yielding a sensitivity of 96.4% while it increased to 100% when any one parameters showed positive result.
Conclusion: DWI showed highest sensitivity of detection compared to DCEMRI and MRS. Multi-parametric approach yielded 96.4% and 100% sensitivity when any two or one of the three parameters was taken as positive for malignancy, respectively. Also the results demonstrated that addition of DWI and MRS play a significant role in establishing the final diagnosis of malignancy, especially in cases where DCEMRI is indeterminate.
Keywords: Apparent diffusion coefficient; Breast cancer; Diffusion-weighted imaging; Dynamic contrast enhanced MRI; Indeterminate DCE; Magnetic resonance spectroscopy; tCho.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.Eur J Radiol. 2016 May;85(5):979-86. doi: 10.1016/j.ejrad.2016.02.022. Epub 2016 Feb 26. Eur J Radiol. 2016. PMID: 27130059
-
Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.Invest Radiol. 2018 Oct;53(10):587-595. doi: 10.1097/RLI.0000000000000465. Invest Radiol. 2018. PMID: 29620604 Free PMC article.
-
Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.Eur Radiol. 2016 Jun;26(6):1565-74. doi: 10.1007/s00330-015-4000-0. Epub 2015 Sep 19. Eur Radiol. 2016. PMID: 26385807
-
Diagnostic performance of diffusion-weighted imaging combined with dynamic contrast-enhanced magnetic resonance imaging for prostate cancer: a systematic review and meta-analysis.Acta Radiol. 2021 Sep;62(9):1238-1247. doi: 10.1177/0284185120956269. Epub 2020 Sep 9. Acta Radiol. 2021. PMID: 32903025
-
Clinical Breast MR Using MRS or DWI: Who Is the Winner?Front Oncol. 2016 Oct 28;6:217. doi: 10.3389/fonc.2016.00217. eCollection 2016. Front Oncol. 2016. PMID: 27840809 Free PMC article. Review.
Cited by
-
The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI.Cancer Imaging. 2020 Dec 14;20(1):88. doi: 10.1186/s40644-020-00365-4. Cancer Imaging. 2020. PMID: 33317609 Free PMC article.
-
Is Elevated Choline on Magnetic Resonance Spectroscopy a Reliable Marker of Breast Lesion Malignancy?Front Oncol. 2021 Sep 10;11:610354. doi: 10.3389/fonc.2021.610354. eCollection 2021. Front Oncol. 2021. PMID: 34567998 Free PMC article.
-
Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism.Metabolites. 2022 Mar 27;12(4):295. doi: 10.3390/metabo12040295. Metabolites. 2022. PMID: 35448482 Free PMC article. Review.
-
Diagnostic Value of Dynamic Enhanced Magnetic Resonance Imaging Combined with Serum CA15-3, CYFRA21-1, and TFF1 for Breast Cancer.J Healthc Eng. 2022 Mar 29;2022:7984591. doi: 10.1155/2022/7984591. eCollection 2022. J Healthc Eng. 2022. PMID: 35392152 Free PMC article.
-
XGboost Prediction Model Based on 3.0T Diffusion Kurtosis Imaging Improves the Diagnostic Accuracy of MRI BiRADS 4 Masses.Front Oncol. 2022 Mar 17;12:833680. doi: 10.3389/fonc.2022.833680. eCollection 2022. Front Oncol. 2022. PMID: 35372060 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical